$ABPI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCENTIA BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACCENTIA BIOPHARMACEUTICALS INC. Get notifications about new insider transactions in ACCENTIA BIOPHARMACEUTICALS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | RYLL TIMOTHY D | 10% Owner | Option Exercise | C | 0.00 | 942,191 | 0 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | RYLL TIMOTHY D | 10% Owner | Grant | A | 8.00 | 50,000 | 400,000 | 3,628,821 | 3.6 M to 3.6 M (+1.40 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | RYLL TIMOTHY D | 10% Owner | Sell | C | 0.00 | 1,418,215 | 0 | 0 | 1.4 M to 0 (-100.00 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | RYLL TIMOTHY D | 10% Owner | Buy | C | 0.00 | 2,700,045 | 0 | 3,578,821 | 878.8 K to 3.6 M (+307.25 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | PHARMACEUTICAL PRODUCT DEVELOP ... | 10% Owner | Buy | C | 0.00 | 4,270,323 | 0 | 4,270,323 | 0 to 4.3 M |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | PHARMACEUTICAL PRODUCT DEVELOP ... | 10% Owner | Sell | C | 0.00 | 7,125,213 | 0 | 0 | 7.1 M to 0 (-100.00 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Option Exercise | C | 0.00 | 320,205 | 0 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Option Exercise | C | 0.00 | 1,603,173 | 0 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Option Exercise | C | 0.00 | 612,602 | 0 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Option Exercise | C | 2.22 | 2,252 | 4,999 | 2,252 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Option Exercise | C | 1.05 | 4,750 | 4,988 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Grant | A | 8.00 | 200,000 | 1,600,000 | 4,381,659 | 4.2 M to 4.4 M (+4.78 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Grant | A | 8.00 | 100,000 | 800,000 | 100,000 | 0 to 100 K |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Sell | C | 0.00 | 1,167,101 | 0 | 0 | 1.2 M to 0 (-100.00 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | ODONNELL FRANCIS E JR | Chief Executive Off ... | Buy | C | 0.00 | 2,129,170 | 0 | 4,181,659 | 2.1 M to 4.2 M (+103.74 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | PEARCE ALLAN | Chief Financial Off ... | Option Exercise | C | 0.00 | 237,507 | 0 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | PEARCE ALLAN | Chief Financial Off ... | Grant | A | 8.00 | 31,250 | 250,000 | 648,768 | 617.5 K to 648.8 K (+5.06 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | PEARCE ALLAN | Chief Financial Off ... | Buy | C | 0.00 | 237,507 | 0 | 617,518 | 380 K to 617.5 K (+62.50 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Option Exercise | C | 2.11 | 1,663 | 3,509 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Option Exercise | C | 1.05 | 9,500 | 9,975 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Option Exercise | C | 2.11 | 1,900 | 4,009 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Option Exercise | C | 2.11 | 2,251 | 4,750 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Option Exercise | C | 1.05 | 35,626 | 37,407 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Option Exercise | C | 4.45 | 788 | 3,507 | 24,145 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Option Exercise | C | 0.00 | 261,258 | 0 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Option Exercise | C | 0.00 | 193,806 | 0 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Option Exercise | C | 0.00 | 684,386 | 0 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Option Exercise | C | 2.22 | 4,503 | 9,997 | 24,145 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Option Exercise | C | 4.45 | 901 | 4,009 | 24,145 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Option Exercise | C | 4.45 | 1,067 | 4,748 | 24,145 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Option Exercise | C | 2.22 | 16,887 | 37,489 | 24,145 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Grant | A | 8.00 | 5,000 | 40,000 | 329,399 | 324.4 K to 329.4 K (+1.54 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Buy | C | 0.00 | 123,836 | 0 | 123,836 | 0 to 123.8 K |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Buy | C | 0.00 | 91,863 | 0 | 91,863 | 0 to 91.9 K |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | BAUM MARTIN | Pres, COO, Specialt ... | Buy | C | 0.00 | 324,399 | 0 | 324,399 | 0 to 324.4 K |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | RYLL DENNIS L | Director | Option Exercise | C | 0.00 | 355,783 | 0 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | RYLL DENNIS L | Director | Option Exercise | C | 0.00 | 1,781,304 | 0 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | RYLL DENNIS L | Director | Option Exercise | C | 0.00 | 942,191 | 0 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | RYLL DENNIS L | Director | Grant | A | 8.00 | 50,000 | 400,000 | 3,628,821 | 3.6 M to 3.6 M (+1.40 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | RYLL DENNIS L | Director | Sell | C | 0.00 | 1,418,215 | 0 | 0 | 1.4 M to 0 (-100.00 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | RYLL DENNIS L | Director | Sell | C | 0.00 | 57,002 | 0 | 0 | 57 K to 0 (-100.00 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | RYLL DENNIS L | Director | Buy | C | 0.00 | 2,700,045 | 0 | 3,578,821 | 878.8 K to 3.6 M (+307.25 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | RYLL DENNIS L | Director | Buy | C | 0.00 | 34,162 | 0 | 34,162 | 0 to 34.2 K |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | ARIKIAN STEVEN | Pres, COO, Biopharm ... | Option Exercise | C | 0.00 | 1,860,164 | 0 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | ARIKIAN STEVEN | Pres, COO, Biopharm ... | Buy | C | 0.00 | 950,544 | 0 | 950,544 | 0 to 950.5 K |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | MOAB INVESTMENT LP | 10% Owner | Option Exercise | C | 0.00 | 355,783 | 0 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | MOAB INVESTMENT LP | 10% Owner | Option Exercise | C | 0.00 | 1,781,304 | 0 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | MOAB INVESTMENT LP | 10% Owner | Option Exercise | C | 0.00 | 942,191 | 0 | 0 | |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | MOAB INVESTMENT LP | 10% Owner | Grant | A | 8.00 | 50,000 | 400,000 | 3,628,821 | 3.6 M to 3.6 M (+1.40 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | MOAB INVESTMENT LP | 10% Owner | Sell | C | 0.00 | 1,418,215 | 0 | 0 | 1.4 M to 0 (-100.00 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | MOAB INVESTMENT LP | 10% Owner | Buy | C | 0.00 | 2,700,045 | 0 | 3,578,821 | 878.8 K to 3.6 M (+307.25 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | DUBINSKY JOHN P | Director | Sell | C | 0.00 | 237,508 | 0 | 0 | 237.5 K to 0 (-100.00 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | DUBINSKY JOHN P | Director | Buy | C | 0.00 | 142,344 | 0 | 142,344 | 0 to 142.3 K |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | STOGEL STEVEN J | Director | Grant | A | 8.00 | 24,000 | 192,000 | 432,159 | 408.2 K to 432.2 K (+5.88 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | STOGEL STEVEN J | Director | Sell | C | 0.00 | 522,516 | 0 | 0 | 522.5 K to 0 (-100.00 %) |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | STOGEL STEVEN J | Director | Buy | C | 0.00 | 313,156 | 0 | 313,156 | 0 to 313.2 K |
| Nov 04 2005 | ABPI | ACCENTIA BIOPHARMA ... | HOLMAN C RAY | Director | Grant | A | 8.00 | 43,750 | 350,000 | 43,750 | 0 to 43.8 K |
| Oct 31 2005 | ABPI | ACCENTIA BIOPHARMA ... | HOLMAN C RAY | Director | Option Exercise | A | 8.00 | 13,333 | 106,664 | 40,000 | |
| Oct 31 2005 | ABPI | ACCENTIA BIOPHARMA ... | HOLMAN C RAY | Director | Option Exercise | A | 8.00 | 13,334 | 106,672 | 26,667 | |
| Oct 31 2005 | ABPI | ACCENTIA BIOPHARMA ... | HOLMAN C RAY | Director | Option Exercise | A | 8.00 | 13,333 | 106,664 | 13,333 | |
| Oct 31 2005 | ABPI | ACCENTIA BIOPHARMA ... | DUBINSKY JOHN P | Director | Option Exercise | A | 8.00 | 15,000 | 120,000 | 45,000 | |
| Oct 31 2005 | ABPI | ACCENTIA BIOPHARMA ... | DUBINSKY JOHN P | Director | Option Exercise | A | 8.00 | 15,000 | 120,000 | 30,000 | |
| Oct 31 2005 | ABPI | ACCENTIA BIOPHARMA ... | DUBINSKY JOHN P | Director | Option Exercise | A | 8.00 | 15,000 | 120,000 | 15,000 | |
| Oct 31 2005 | ABPI | ACCENTIA BIOPHARMA ... | SCHUBERT DAVID M | Director | Option Exercise | A | 8.00 | 8,333 | 66,664 | 25,000 | |
| Oct 31 2005 | ABPI | ACCENTIA BIOPHARMA ... | SCHUBERT DAVID M | Director | Option Exercise | A | 8.00 | 8,334 | 66,672 | 16,667 | |
| Oct 31 2005 | ABPI | ACCENTIA BIOPHARMA ... | SCHUBERT DAVID M | Director | Option Exercise | A | 8.00 | 8,333 | 66,664 | 8,333 | |
| Oct 31 2005 | ABPI | ACCENTIA BIOPHARMA ... | STOGEL STEVEN J | Director | Option Exercise | A | 8.00 | 10,000 | 80,000 | 30,000 | |
| Oct 31 2005 | ABPI | ACCENTIA BIOPHARMA ... | STOGEL STEVEN J | Director | Option Exercise | A | 8.00 | 10,000 | 80,000 | 20,000 | |
| Oct 31 2005 | ABPI | ACCENTIA BIOPHARMA ... | STOGEL STEVEN J | Director | Option Exercise | A | 8.00 | 10,000 | 80,000 | 10,000 |